Clinical trials
Phase 4 Surgical Wound Infection trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 7 |
| Recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Texas Health Science Center, Houston | 2 |
| The University of Texas Medical Branch, Galveston | 2 |
| University of Maryland, Baltimore | 2 |
| Acibadem Maslak Hospital | 1 |
| Beth Israel Medical Center | 1 |
| Boston Children's Hospital | 1 |
| Boston Medical Center | 1 |
| Carilion Clinic | 1 |
| Halyard Health | 1 |
| Hyagriv Simhan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Surgical Wound Infection | 39 |
| Fractures, Open | 4 |
| Infections | 4 |
| Wound Infection | 3 |
| Dysbiosis | 2 |
| Pneumonia | 2 |
| Surgical Wound | 2 |
| Bacteremia | 1 |
| Bacterial Infections | 1 |
| Cystitis | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.